Farms.com Home   News

CDC Raises Support Prices

The Canadian Dairy Commission has announced it is increasing the support prices for butter and skim milk powder.

The support price for butter will increase from $7.2810 to $7.3379 per kg, and the support price for skim milk powder will increase from $6.3673 to $6.4170 per kg.

These are the amounts at which the CDC buys and sells butter and skim milk powder on the domestic market. They are used as references by the provincial dairy marketing boards to price industrial milk, which is used to make products like yogurt, cheese and butter.

"The change in support price reflects the increase in the cost of inputs, especially the cost of feed," says CDC chair Randy Williamson, Chairman of the CDC. "However, it remains considerably lower than the rate of inflation for food which currently stands at 2.4 percent."

The increase in support prices are expected to translate into a revenue increase of 0.9 percent for producers of industrial millk.

The changes are effective April 1st.

Source: PortageOnline


Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.